Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

SHA:688739 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,469	1,676	1,750	1,815	2,088	1,996
Revenue Growth (YoY)	-14.47%	-4.22%	-3.58%	-13.08%	4.63%	19.00%
Cost of Revenue	319.92	319.24	342.56	243.28	220.37	279.08
Gross Profit	1,150	1,357	1,408	1,572	1,868	1,716
Selling, General & Admin	636.05	659.02	648.29	588.41	603.58	507.42
Research & Development	284.97	281.94	219.96	210.89	236.82	222.37
Other Operating Expenses	24.61	22.63	21.86	22.1	20.82	17.05
Operating Expenses	960.62	972.25	902.89	836.49	877.65	740.58
Operating Income	188.9	384.75	504.66	735.23	990.02	975.92
Interest Expense	-1.41	-1.58	-1.42	-1.32	-1.54	-
Interest & Investment Income	63.92	70.5	96.81	128.3	45.81	42.58
Currency Exchange Gain (Loss)	0.84	0.84	2.47	2.5	-0.48	-1.04
Other Non Operating Income (Expenses)	2.14	-0.28	-0.82	-0.47	-0.42	-0.64
EBT Excluding Unusual Items	254.39	454.22	601.71	864.25	1,033	1,017
Gain (Loss) on Sale of Investments	-61.07	-75.57	-45.29	-43.63	-25.53	51.19
Gain (Loss) on Sale of Assets	-2.27	-1.72	1.61	-0.79	-0.69	-23.66
Asset Writedown	-7.57	-	-	-	-	-
Other Unusual Items	25.54	26.08	18.36	18.25	23.81	18.57
Pretax Income	209.01	403.02	576.38	838.07	1,031	1,063
Income Tax Expense	31.07	60.2	110.46	124.05	138.49	144.72
Net Income	177.94	342.82	465.92	714.02	892.49	918.19
Net Income to Common	177.94	342.82	465.92	714.02	892.49	918.19
Net Income Growth	-46.42%	-26.42%	-34.75%	-20.00%	-2.80%	31.48%
Shares Outstanding (Basic)	413	413	416	418	381	375
Shares Outstanding (Diluted)	413	413	416	418	381	375
Shares Change (YoY)	0.26%	-0.71%	-0.37%	9.48%	1.77%	-0.18%
EPS (Basic)	0.43	0.83	1.12	1.71	2.34	2.45
EPS (Diluted)	0.43	0.83	1.12	1.71	2.34	2.45
EPS Growth	-46.56%	-25.89%	-34.50%	-26.92%	-4.49%	31.72%
Free Cash Flow	26.34	138.48	125.02	34.89	-1.97	671.35
Free Cash Flow Per Share	0.06	0.34	0.30	0.08	-0.01	1.79
Dividend Per Share	0.800	0.800	0.800	1.000	1.000	-
Dividend Growth	-	-	-20.00%	-	-	-
Gross Margin	78.23%	80.95%	80.43%	86.60%	89.45%	86.02%
Operating Margin	12.86%	22.95%	28.84%	40.51%	47.41%	48.90%
Profit Margin	12.11%	20.45%	26.62%	39.34%	42.74%	46.01%
Free Cash Flow Margin	1.79%	8.26%	7.14%	1.92%	-0.09%	33.64%
EBITDA	387.51	549.77	624.89	851.42	1,101	1,041
EBITDA Margin	26.37%	32.80%	35.71%	46.91%	52.73%	52.15%
D&A For EBITDA	198.62	165.02	120.24	116.19	111.07	64.84
EBIT	188.9	384.75	504.66	735.23	990.02	975.92
EBIT Margin	12.86%	22.95%	28.84%	40.51%	47.41%	48.90%
Effective Tax Rate	14.87%	14.94%	19.16%	14.80%	13.43%	13.62%
Revenue as Reported	1,469	1,676	1,750	1,815	2,088	1,996

Source: S&P Global Market Intelligence. Standard template. Financial Sources.